Cord Blood 2.0®

Cord Blood 2.02020-04-16T22:30:46+00:00
Cord Blood Icon High Res 93 - Cord Blood 2.0

Cord Blood 2.0®

Cord Blood 2.0® is an entirely proprietary system developed by Americord. While other cord blood collection options exist, Americord’s Cord Blood 2.0® can gather up to twice as many stem cells as competitor collection methods.

Cord Blood 2.0® has been widely recognized throughout our industry for yielding above average collections:

“Compared to traditional cord blood stem cell collections systems, the Cord Blood 2.0® can obtain substantially greater quantities of stem cells for preservation. The main advantage that results is that the cord blood units can be used for hematopoietic stem cell transplant in patients who are larger in size. Historically, the volume of stem cells preserved during traditional processing of a cord blood unit has only been sufficient to allow for the treatment of patients up to 60-70 pounds.”

-BioInformant Report, 2017

More Stem Cells = More Options. It’s that simple.

cordblood—testtube-img

Collect up to twice as many stem cells as the industry standard with Cord Blood 2.0®

cordblood img

Collect up to twice as many stem cells as the industry standard with Cord Blood 2.0®

Before this innovation, a typical cord blood collection frequently could only preserve enough stem cells to treat a person that weighed up to 65 lbs. With Cord Blood 2.0®, we can collect enough stem cells to treat individuals up to 165 lbs, depending on the medical collection and treatment requirements.

This means that Americord helps parents protect their children into adolescence and even potentially into adulthood and expands treatment opportunities for smaller patients, who still may benefit from the greater number of stem cells available to carry out treatment.

We’re committed to making this valuable stem cell resource a more feasible treatment option for more people.

ENROLL

Cord Blood - Cord Blood 2.0

Cord Blood 2.0®

$3,499 OR $165 FOR 24 MONTHS.

enroll

Cord blood banking is the safe and painless process of collecting and storing the remaining blood in your newborn’s umbilical cord after the medical provider clamps the cord. Americord cryo-preserves all stored blood until such a time that your child may need it.

Cord blood is full of easily-collected hematopoietic stem cells that are FDA-approved to treat close to 100 medical conditions. Many also recognize the treatment potential demonstrated in clinical trials for treatments for conditions including autism, cerebral palsy, and diabetes and take the opportunity to essentially buy into the future of stem cell medicine.

After the umbilical cord is clamped and all essential care for the baby and mother is provided, the doctor withdraws the blood that remains in the cord into an Americord-provided collection kit. This kit is then picked up by a medical courier and taken to our laboratory, where the stem cells are processed for cryopreservation.

All families should strongly consider the medical benefits of cord blood banking. Families with a history of conditions that can be treated by these stem cells, or have promising clinical trials underway for those conditions, may have an increased incentive to bank these stem cells. In the United States, families with ethnic minority and mixed ethnic backgrounds frequently have a more difficult time obtaining donor stem cells, and should consider stem cell banking to assure a match is available, should treatment be required in the future.

There are close to 100 conditions that can be treated with cord blood stem cells. The majority of the currently approved treatments are for conditions of the blood, including leukemias and anemias. However, there are other conditions, including lymphomas and certain types of multiple sclerosis, that can also be treated with these cells. There are also advanced clinical trials for many more conditions, including cerebral palsy, autism, and diabetes.

Cord blood stem cells can frequently be used to treat siblings, and in fact many of the treatments these stem cells have been used for have been for siblings. There is a 50% chance that cord blood is a match for a sibling, so when possible families should bank all of their children’s cord blood to ensure the greatest possibility of a match, should treatment be required.

All evidence suggests cord blood can be stored indefinitely in proper conditions. Americord’s most common storage plan is for 20-year terms, which can be extended at any time. We also provide lifetime storage plans.

Individual families must decide if they wish to invest in the future of stem cell medicine with cord blood banking. There are dozens of established treatments and the advancement of clinical trials for a host of other conditions has the future looking brighter than ever, leading tens of thousands of parents to choose to take this once-in-a-lifetime opportunity every year.

The first transplant of cord blood stem cells took place in 1988, although stem cell medicine was successfully established almost 70 years ago, when the first successful bone marrow transplant was carried out in 1956. The first cord blood bank was formed in 1992, and Americord was founded in 2008.

Americord has flexible payment options to make cord blood banking as affordable as possible for more families, including one-time, annual, and monthly payment plans. First-year costs can be as low as $1,549.

Private cord blood banking is the practice of storing a baby’s stem cells for use by the family that banked them. The family owns the stem cells. Public cord blood banking involves donating the stem cells to a bank that any match can draw from. However, nearly 70% of donated cord blood is discarded, and it can cost upwards of $50,000 to withdraw these stem cells, making it far more expensive than private banking.